Open Label Design News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Depressive symptoms, cognition, and memory improved inpatients with comorbid dementia and depression, but the 12-week trial of the expensive antidepressant was small and open-label.

Claire sextonMichael cronquist christensenAlzheimer associationDrug administrationMedscape medical newsClinical trialsDepression rating scaleOpen label designAlzheimers diseaseLzheimer diseaseAntidepressant drugRug antidepressantQuality of lifeEalth related quality of lifeInpatient careSelective serotonin reuptake inhibitor ssri